To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TAGLNTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
487 representative clones for gene TAGLN back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU846075 ovary, teratocarcinoma, cell line .a 1 to 912 1 to 924 E170G H173S V174M I175S G176L ... tiling clone,   924/926
(99 %)
28 diff
(97.0 %id)
NM_003186.3   .a 5 to 1163 1 to 1159 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1159/1159
(100 %)
0 diff
(100 %id)
BM694189 eye, RPE and Choroid .a 10 to 517 1 to 508       508/508
(100 %)
0 diff
(100 %id)
BM704720 eye, RPE and Choroid .a 10 to 622 1 to 613       613/613
(100 %)
0 diff
(100 %id)
ES315610 occipital scalp hair, skin .a 17 to 158 1 to 142       142/142
(100 %)
0 diff
(100 %id)
DB493969 hypothalamus .a 18 to 542 1 to 525       525/525
(100 %)
0 diff
(100 %id)
CX758656 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 31 to 797 1 to 760 exact   Submitted on the opposite strand 760/845
(89 %)
8 diff
(99.1 %id)
M95787 skin .a 51 to 1132 1 to 1083 R49P Y104S     1083/1083
(100 %)
7 diff
(99.4 %id)
BM762113 myeloma .a 51 to 674 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BP373151 umbilical cord .a 51 to 631 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP373657 umbilical cord .a 51 to 631 1 to 581       581/581
(100 %)
0 diff
(100 %id)
R79660 placenta .a 53 to 169 1 to 117       117/117
(100 %)
7 diff
(94.1 %id)
BP373511 umbilical cord .a 54 to 633 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DB502198 hypothalamus .a 55 to 527 1 to 473       473/473
(100 %)
0 diff
(100 %id)
AK314043 uterus .a 56 to 731 1 to 676 exact     676/676
(100 %)
0 diff
(100 %id)
DB455070 testis .a 59 to 550 1 to 492       492/492
(100 %)
0 diff
(100 %id)
ES309465 occipital hair of pubic hypotrichosispatient, skin .a 60 to 484 21 to 446       426/755
(56 %)
5 diff
(99.4 %id)
ES313094 beard hair, skin .a 60 to 184 1 to 125       125/125
(100 %)
0 diff
(100 %id)
CR605812 Placenta Cot 25-normalized .a 61 to 1177 1 to 1117 exact tiling clone,   1117/1117
(100 %)
0 diff
(100 %id)
BX377865 Placenta Cot 25-normalized .a 61 to 550 1 to 490   fully sequenced, AAA   490/490
(100 %)
0 diff
(100 %id)
BM709124 eye, RPE and Choroid .a 61 to 397 1 to 337       337/337
(100 %)
0 diff
(100 %id)
BC093050 White Matter pool- 5 brain tissues- femoralartery, olfactory tract, optic tract, cerebellar whitematter, cerebral white matter. .a 62 to 1178 1 to 1120 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1120/1120
(100 %)
1 diff
(100.0 %id)
CN274019 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 62 to 751 1 to 690 exact     690/690
(100 %)
0 diff
(100 %id)
CN485284 eye .a 62 to 605 1 to 544       544/544
(100 %)
0 diff
(100 %id)
BI761246 pooled colon, kidney, stomach .a 62 to 900 1 to 840 exact     840/841
(99 %)
9 diff
(99.0 %id)
BI760162 pooled colon, kidney, stomach .a 62 to 950 1 to 884 Q187R A188P G189A M190*     884/886
(99 %)
34 diff
(96.2 %id)
TI_154190135   .a 62 to 417 48 to 408       361/367
(98 %)
7 diff
(98.1 %id)
CN274178 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 63 to 730 1 to 668       668/668
(100 %)
1 diff
(99.9 %id)
CR594882 placenta .a 63 to 1139 1 to 1077 exact     1077/1077
(100 %)
0 diff
(100 %id)
ES311540 frontal balding hair, skin .a 63 to 230 1 to 169       169/169
(100 %)
1 diff
(99.5 %id)
ES312296 frontal balding hair, skin .a 63 to 259 1 to 197       197/197
(100 %)
1 diff
(99.5 %id)
BG742579 skin .a 63 to 797 1 to 732 exact     732/741
(98 %)
4 diff
(99.5 %id)
BQ721359 sympathetic trunk .a 63 to 936 1 to 883 R197X     883/883
(100 %)
13 diff
(98.6 %id)
AI750770 Bone, Hip .a 63 to 442 1 to 384       384/384
(100 %)
11 diff
(97.2 %id)
BM705199 eye, RPE and Choroid .a 63 to 651 1 to 589       589/589
(100 %)
0 diff
(100 %id)
CR592460 Placenta Cot 25-normalized .a 64 to 1127 1 to 1064 exact     1064/1064
(100 %)
0 diff
(100 %id)
CR606909 adult brain .a 64 to 1115 1 to 1052 exact     1052/1052
(100 %)
0 diff
(100 %id)
CR615909 Placenta Cot 25-normalized .a 64 to 1129 1 to 1066 exact     1066/1066
(100 %)
0 diff
(100 %id)
BG110652 Bone, osteosarcoma, cell line .a 64 to 832 1 to 773 A185G S186L Q187P A188R G189P ...     773/886
(87 %)
16 diff
(98.2 %id)
BU150482 dorsal root ganglia .a 64 to 932 1 to 883 exact     883/955
(92 %)
24 diff
(97.5 %id)
CD723461 eye, lacrimal gland .a 64 to 706 1 to 643       643/643
(100 %)
0 diff
(100 %id)
CD616541   .a 65 to 220 158 to 3       156/158
(98 %)
0 diff
(100 %id)
CN274197 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 65 to 730 1 to 666       666/666
(100 %)
1 diff
(99.9 %id)
BU542512 carcinoma, cell line, Prostate .a 65 to 978 1 to 920 exact     920/920
(100 %)
10 diff
(99.0 %id)
CK430937 eye, lacrimal gland .a 65 to 594 1 to 530       530/530
(100 %)
0 diff
(100 %id)
BG121049 adenocarcinoma, cell line, Liver .a 66 to 811 1 to 745 S186P Q187R A188P G189A M190*     745/1111
(67 %)
20 diff
(98.2 %id)
CN274033 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 67 to 730 1 to 664       664/664
(100 %)
0 diff
(100 %id)
CN274191 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 67 to 735 1 to 669 exact     669/669
(100 %)
0 diff
(100 %id)
ES308816 beard hair, skin .a 67 to 194 1 to 129       129/129
(100 %)
1 diff
(99.3 %id)
BI754694 brain .a 67 to 894 1 to 822 exact     822/907
(90 %)
17 diff
(98.2 %id)
CD616561   .a 68 to 743 1 to 676 exact     676/676
(100 %)
0 diff
(100 %id)
CN274148 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 68 to 651 1 to 584       584/584
(100 %)
0 diff
(100 %id)
CR597887 placenta .a 68 to 1132 1 to 1065 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1065/1065
(100 %)
0 diff
(100 %id)
CR600882 Placenta Cot 25-normalized .a 68 to 1096 1 to 1029 exact     1029/1029
(100 %)
0 diff
(100 %id)
BG741477 skin .a 68 to 921 1 to 856 exact     856/859
(99 %)
11 diff
(98.8 %id)
BI822174 pooled brain, lung, testis .a 68 to 986 1 to 921 exact     921/922
(99 %)
25 diff
(97.3 %id)
BM552971 brain, medulla .a 68 to 1011 1 to 953 exact     953/1134
(84 %)
17 diff
(98.6 %id)
BU579541 insulinoma, Pancreas .a 68 to 494 1 to 427       427/427
(100 %)
5 diff
(98.9 %id)
BQ720075 sympathetic trunk .a 68 to 933 1 to 883 exact     883/897
(98 %)
30 diff
(96.7 %id)
CX755039 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 68 to 799 1 to 732 exact   Submitted on the opposite strand 732/732
(100 %)
0 diff
(100 %id)
BM698159 eye, fetal eyes .a 68 to 657 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BM722505 eye, fetal eye .a 68 to 617 1 to 550   fully sequenced,   550/550
(100 %)
0 diff
(100 %id)
CD616539   .a 69 to 220 154 to 2       153/154
(99 %)
0 diff
(100 %id)
CN274045 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 69 to 634 1 to 566       566/566
(100 %)
0 diff
(100 %id)
CR626280 Placenta Cot 25-normalized .a 69 to 1132 1 to 1064 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1064/1064
(100 %)
0 diff
(100 %id)
ES309442 occipital hair of pubic hypotrichosispatient, skin .a 69 to 484 23 to 436       414/665
(62 %)
8 diff
(98.8 %id)
CN484754 eye .a 69 to 673 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BI758168 brain .a 69 to 984 1 to 916 exact     916/917
(99 %)
34 diff
(96.3 %id)
BQ072545 pooled lung and spleen .a 69 to 1076 1 to 1019 exact     1019/1020
(99 %)
30 diff
(97.1 %id)
CX754733 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 69 to 861 1 to 785 exact   Submitted on the opposite strand 785/785
(100 %)
9 diff
(98.9 %id)
EB388771 eye, optic nerve .a 69 to 885 1 to 817 exact     817/817
(100 %)
0 diff
(100 %id)
BF734009 amnion_normal .a 70 to 195 126 to 1     Submitted on the opposite strand 126/126
(100 %)
3 diff
(97.7 %id)
BQ901037 sympathetic trunk .a 70 to 917 1 to 853 exact     853/854
(99 %)
9 diff
(99.0 %id)
BQ949947 sciatic nerve .a 70 to 987 1 to 922 exact     922/925
(99 %)
12 diff
(98.8 %id)
CN274093 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 71 to 686 1 to 616       616/616
(100 %)
0 diff
(100 %id)
CN274138 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 71 to 756 1 to 686 exact     686/686
(100 %)
1 diff
(99.9 %id)
ES314919 occipital scalp hair, skin .a 71 to 229 1 to 158       158/158
(100 %)
1 diff
(99.4 %id)
BU543380 carcinoma, cell line, Prostate .a 71 to 937 1 to 871 exact     871/871
(100 %)
4 diff
(99.6 %id)
BU553308 ovary, teratocarcinoma, cell line .a 71 to 940 1 to 870 exact     870/871
(99 %)
8 diff
(99.1 %id)
BU846266 ovary, teratocarcinoma, cell line .a 71 to 979 1 to 923 exact     923/923
(100 %)
25 diff
(97.3 %id)
BU553987 ovary, teratocarcinoma, cell line .a 71 to 852 1 to 786 exact     786/920
(85 %)
12 diff
(98.7 %id)
BU856432 ovary, teratocarcinoma, cell line .a 71 to 971 1 to 905 S201X     905/927
(97 %)
17 diff
(98.2 %id)
ES308216 beard hair, skin .a 72 to 207 1 to 136       136/136
(100 %)
0 diff
(100 %id)
BG674143 skin .a 72 to 768 1 to 700 S186V Q187P A188G G189R M190Q ...     700/871
(80 %)
7 diff
(99.2 %id)
CD515502 White Matter .a 72 to 817 1 to 753 exact     753/889
(84 %)
9 diff
(99.0 %id)
CN274114 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 73 to 855 1 to 784 exact     784/784
(100 %)
2 diff
(99.8 %id)
CN274179 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 73 to 811 1 to 739 exact     739/739
(100 %)
1 diff
(99.9 %id)
CA397259 eye, RPE/choroid .a 73 to 594 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BI771512 pooled lung and spleen .a 73 to 987 1 to 915 exact     915/915
(100 %)
21 diff
(97.8 %id)
CD616533   .a 74 to 726 1 to 651       651/651
(100 %)
2 diff
(99.7 %id)
CN274068 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 74 to 775 7 to 708 exact     702/708
(99 %)
1 diff
(99.9 %id)
CN274177 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 74 to 810 1 to 739 exact     739/739
(100 %)
2 diff
(99.8 %id)
BP423025 small intestine .a 75 to 579 1 to 505     Submitted on the opposite strand 505/505
(100 %)
0 diff
(100 %id)
BI826644 brain, medulla .a 75 to 986 1 to 908 exact     908/908
(100 %)
21 diff
(97.7 %id)
BU556884 ovary, teratocarcinoma, cell line .a 75 to 988 1 to 918 exact     918/926
(99 %)
21 diff
(97.8 %id)
BU849208 ovary, teratocarcinoma, cell line .a 75 to 957 1 to 888 exact     888/890
(99 %)
13 diff
(98.6 %id)
BU855466 ovary, teratocarcinoma, cell line .a 75 to 938 1 to 873 exact     873/873
(100 %)
10 diff
(98.9 %id)
BU859093 ovary, teratocarcinoma, cell line .a 75 to 857 1 to 786 exact     786/885
(88 %)
8 diff
(99.1 %id)
ES314802 occipital scalp hair, skin .a 76 to 209 1 to 134       134/134
(100 %)
0 diff
(100 %id)
BQ720262 sympathetic trunk .a 76 to 850 1 to 782 exact     782/961
(81 %)
15 diff
(98.5 %id)
CN274052 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 77 to 807 1 to 731 exact     731/731
(100 %)
0 diff
(100 %id)
CN274109 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 77 to 628 1 to 552       552/552
(100 %)
0 diff
(100 %id)
CN274123 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 77 to 848 1 to 771 exact     771/771
(100 %)
1 diff
(99.9 %id)
CN274069 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 78 to 720 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
CN274080 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 78 to 663 1 to 586       586/586
(100 %)
0 diff
(100 %id)
CN274124 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 78 to 767 1 to 690 exact     690/690
(100 %)
0 diff
(100 %id)
BX093514   .a 79 to 799 1 to 721 exact     721/721
(100 %)
1 diff
(99.9 %id)
D17409 aorta .a 79 to 1132 1 to 1054 exact     1054/1056
(99 %)
1 diff
(100.0 %id)
BP420915 small intestine .a 79 to 578 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BE378718 endometrium, adenocarcinoma cell line, uterus .a 79 to 901 1 to 825 P196L R197G Q198R I199S I200S ...     825/833
(99 %)
22 diff
(97.4 %id)
ES311921 frontal balding hair, skin .a 80 to 267 1 to 186       186/186
(100 %)
5 diff
(97.4 %id)
ES314796 occipital scalp hair, skin .a 81 to 210 1 to 131       131/131
(100 %)
2 diff
(98.5 %id)
ES315488 occipital scalp hair, skin .a 81 to 193 1 to 113       113/113
(100 %)
0 diff
(100 %id)
CN274044 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 85 to 856 1 to 774 exact     774/774
(100 %)
2 diff
(99.8 %id)
CN274062 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 85 to 706 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
CN274094 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 85 to 730 1 to 646       646/646
(100 %)
0 diff
(100 %id)
CN274096 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 85 to 733 1 to 649 exact     649/649
(100 %)
0 diff
(100 %id)
CN274139 embryonic stem cells, cell lines H1, H7, andH9 .a 85 to 800 1 to 717 exact     717/717
(100 %)
2 diff
(99.8 %id)
CN274160 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 85 to 809 1 to 726 exact     726/726
(100 %)
1 diff
(99.9 %id)
CN274202 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 85 to 718 1 to 634       634/634
(100 %)
0 diff
(100 %id)
CN274209 embryonic stem cells, cell lines H1, H7, andH9 .a 85 to 729 1 to 645       645/645
(100 %)
0 diff
(100 %id)
CN274235 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 85 to 730 1 to 646       646/646
(100 %)
0 diff
(100 %id)
CN481421 eye .a 85 to 727 1 to 643       643/643
(100 %)
0 diff
(100 %id)
CN274046 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 86 to 736 1 to 651 exact     651/652
(99 %)
1 diff
(99.9 %id)
CN274116 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 86 to 787 1 to 702 exact     702/702
(100 %)
0 diff
(100 %id)
CN274171 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 86 to 845 1 to 760 exact     760/760
(100 %)
1 diff
(99.9 %id)
ES315297 occipital scalp hair, skin .a 86 to 243 1 to 158       158/158
(100 %)
0 diff
(100 %id)
ES314609 occipital scalp hair, skin .a 87 to 215 1 to 129       129/129
(100 %)
0 diff
(100 %id)
ES312512 frontal balding hair, skin .a 88 to 290 1 to 203       203/203
(100 %)
2 diff
(99.1 %id)
CR612359 Placenta Cot 25-normalized .a 93 to 1132 1 to 1040 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1040/1040
(100 %)
0 diff
(100 %id)
ES314270 occipital scalp hair, skin .a 94 to 246 1 to 153       153/153
(100 %)
0 diff
(100 %id)
BM694221 eye, RPE and Choroid .a 94 to 387 1 to 294       294/294
(100 %)
0 diff
(100 %id)
BM708723 eye, RPE and Choroid .a 95 to 565 1 to 471   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 471/471
(100 %)
0 diff
(100 %id)
BM708611 eye, RPE and Choroid .a 95 to 630 1 to 536       536/536
(100 %)
0 diff
(100 %id)
ES315559 occipital scalp hair, skin .a 97 to 217 1 to 121       121/121
(100 %)
0 diff
(100 %id)
ES314596 occipital scalp hair, skin .a 99 to 264 1 to 166       166/166
(100 %)
0 diff
(100 %id)
CN274083 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 101 to 686 1 to 586       586/586
(100 %)
0 diff
(100 %id)
ES315653 occipital scalp hair, skin .a 103 to 242 1 to 140       140/140
(100 %)
0 diff
(100 %id)
CN483217 eye .a 103 to 743 1 to 641 exact     641/641
(100 %)
0 diff
(100 %id)
CN274087 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 105 to 845 2 to 742 exact     741/742
(99 %)
0 diff
(100 %id)
BI770299 pooled lung and spleen .a 105 to 1075 1 to 967 exact     967/971
(99 %)
29 diff
(97.1 %id)
BM694262 eye, RPE and Choroid .a 105 to 649 1 to 545     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 545/545
(100 %)
0 diff
(100 %id)
BU844387 ovary, teratocarcinoma, cell line .a 106 to 987 1 to 885 exact     885/886
(99 %)
8 diff
(99.1 %id)
BQ777879 Pancreas, Purified pancreatic islet .a 107 to 617 1 to 511   fully sequenced,   511/511
(100 %)
0 diff
(100 %id)
BQ942768 sciatic nerve .a 107 to 867 1 to 771 exact     771/821
(93 %)
12 diff
(98.6 %id)
CN274113 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 111 to 706 1 to 596       596/596
(100 %)
0 diff
(100 %id)
CN274152 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 111 to 725 1 to 615       615/615
(100 %)
0 diff
(100 %id)
TI_154062770   .a 308 to 1163 934 to 91   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 844/981
(86 %)
15 diff
(98.5 %id)
TI_149294754   .a 322 to 1160 899 to 71   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 829/985
(84 %)
18 diff
(98.2 %id)
TI_151706375   .a 322 to 1163 921 to 89   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 833/925
(90 %)
20 diff
(97.9 %id)
BM709013 eye, RPE and Choroid .a 423 to 617 1 to 195   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 195/195
(100 %)
0 diff
(100 %id)
BU683386 lung .a 439 to 1160 741 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 723/725
(99 %)
1 diff
(99.9 %id)
BU627036 Bone, Enchondroma cell line .a 453 to 1163 729 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 711/711
(100 %)
0 diff
(100 %id)
BU627069 Bone, Enchondroma cell line .a 453 to 1163 729 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 711/711
(100 %)
0 diff
(100 %id)
BU628758 Bone, Enchondroma cell line .a 482 to 1163 699 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 681/683
(99 %)
2 diff
(99.8 %id)
BQ447157 Knee, Osteoarthritic Cartilage .a 496 to 1167 689 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 671/671
(100 %)
1 diff
(99.9 %id)
BU074279 insulinoma, Pancreas .a 507 to 1146 640 to 1       640/640
(100 %)
0 diff
(100 %id)
BX392469 Placenta Cot 25-normalized .a 520 to 1168 657 to 8   fully sequenced,   650/657
(98 %)
1 diff
(99.9 %id)
CA421269 Bone, Enchondroma cell line .a 534 to 1163 648 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 630/630
(100 %)
0 diff
(100 %id)
BU731917 eye, RPE and Choroid .a 535 to 1163 646 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 628/628
(100 %)
0 diff
(100 %id)
CA413602 Chondrosarcoma Grade II, Left Pelvis .a 551 to 1163 631 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 613/613
(100 %)
0 diff
(100 %id)
BQ777581 Pancreas, Purified pancreatic islet .a 556 to 1132 577 to 1   fully sequenced,   577/577
(100 %)
2 diff
(99.7 %id)
BU730915 eye, RPE and Choroid .a 556 to 1165 629 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 611/611
(100 %)
1 diff
(99.9 %id)
BM679014 eye, fetal eye .a 556 to 1150 594 to 1   fully sequenced,   594/594
(100 %)
1 diff
(99.9 %id)
BF434280 fibrotheoma, ovary .a 615 to 1165 551 to 1       551/551
(100 %)
0 diff
(100 %id)
BU733091 eye, RPE and Choroid .a 689 to 1150 462 to 1       462/462
(100 %)
0 diff
(100 %id)
BU733133 eye, RPE and Choroid .a 690 to 1163 495 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 477/477
(100 %)
3 diff
(99.4 %id)
BU734467 eye, RPE and Choroid .a 839 to 1150 312 to 1       312/312
(100 %)
0 diff
(100 %id)
BC065829 White Matter pool- 5 brain tissues- femoralartery, olfactory tract, optic tract, cerebellar whitematter, cerebral white matter. .b 1 to 1239 1 to 1241 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1241/1241
(100 %)
4 diff
(99.7 %id)
CD517223 White Matter .b 2 to 667 1 to 674       674/780
(86 %)
14 diff
(98.3 %id)
BG673999 skin .b 157 to 980 1 to 832 exact     832/832
(100 %)
11 diff
(98.7 %id)
AI628846 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 667 to 1259 599 to 7       593/690
(85 %)
4 diff
(99.5 %id)
BF939414 Prostate .b 1218 to 1567 352 to 3   tiling clone,   350/352
(99 %)
0 diff
(100 %id)
DB272969 uterus .b 1231 to 1798 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA020943   .b 1239 to 1780 2 to 543   tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
DA916332 small intestine .b 1240 to 1813 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
AA653704 normal prostate, Prostate .b 1295 to 1560 266 to 1       266/266
(100 %)
0 diff
(100 %id)
AW105289 ovary, tumor, 5 pooled (see description) .b 1296 to 1561 268 to 1       268/289
(92 %)
3 diff
(99.0 %id)
BX640723 human rectum tumor .b 1419 to 3914 1 to 2496   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2496/2497
(99 %)
6 diff
(99.8 %id)
CN285439 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1478 to 2119 1 to 642       642/642
(100 %)
0 diff
(100 %id)
AI051182 liver and spleen .b 1511 to 1945 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
DB308804 hippocampus .b 1526 to 2095 1 to 570     Submitted on the opposite strand 570/570
(100 %)
0 diff
(100 %id)
DA556597   .b 1543 to 2097 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB205240 trachea .b 1556 to 2142 2 to 588   tiling clone, capped   587/587
(100 %)
0 diff
(100 %id)
DB209118 trachea .b 1557 to 2019 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
DB011629 esophageal, tumor tissue .b 1577 to 2116 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA869577 Prostate .b 1606 to 2142 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA182596 amygdala .b 1609 to 2121 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DB194349 trachea .b 1875 to 2660 2 to 788   capped   787/791
(99 %)
7 diff
(99.2 %id)
DA011264 adrenal gland .b 1993 to 2542 2 to 551   tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
BQ719227 sympathetic trunk .b 2345 to 3133 1 to 793   tiling clone,   793/939
(84 %)
32 diff
(96.6 %id)
CR594443 Placenta Cot 25-normalized .b 3118 to 3879 1 to 762       762/762
(100 %)
0 diff
(100 %id)
CN484874 eye .b 3133 to 3764 1 to 632       632/632
(100 %)
0 diff
(100 %id)
BM713362 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3176 to 3512 1 to 337   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 337/337
(100 %)
0 diff
(100 %id)
BM694139.
matches multiple genes
eye, RPE and Choroid .b 3279 to 3712 1 to 434   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base), also hits gene plarchey 434/434
(100 %)
1 diff
(99.8 %id)
AI379604 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3416 to 3915 500 to 1       500/500
(100 %)
0 diff
(100 %id)
DB347796 trachea .b 3426 to 3915 494 to 1       494/494
(100 %)
14 diff
(97.2 %id)
BM674702 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3482 to 3915 450 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 432/432
(100 %)
0 diff
(100 %id)
AI085677.
matches multiple genes
senescent fibroblast .b 3496 to 3902 407 to 1     also hits gene plarchey 407/407
(100 %)
0 diff
(100 %id)
AI272903.
matches multiple genes
adenocarcinoma, colon .b 3497 to 3915 419 to 1     also hits gene plarchey 419/419
(100 %)
0 diff
(100 %id)
AW173617.
matches multiple genes
moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3518 to 3726 209 to 1     also hits gene plarchey 209/209
(100 %)
0 diff
(100 %id)
AI926778.
matches multiple genes
poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3521 to 3915 395 to 1     also hits gene plarchey 395/395
(100 %)
0 diff
(100 %id)
AA635880.
matches multiple genes
normal prostate, Prostate .b 3542 to 4010 467 to 1   tiling clone, also hits gene plarchey 467/467
(100 %)
4 diff
(99.2 %id)
AW196046.
matches multiple genes
adenocarcinoma, Pancreas .b 3645 to 3915 271 to 1     also hits gene plarchey 271/271
(100 %)
0 diff
(100 %id)
AI264505.
matches multiple genes
adenocarcinoma, colon .b 3649 to 3915 267 to 1     also hits gene plarchey 267/267
(100 %)
0 diff
(100 %id)
AI915851.
matches multiple genes
Kidney .b 3650 to 3915 266 to 1     also hits gene plarchey 266/266
(100 %)
0 diff
(100 %id)
BU732316.
matches multiple genes
eye, RPE and Choroid .b 3682 to 3915 252 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base), also hits gene plarchey 234/234
(100 %)
0 diff
(100 %id)
AW068957.
matches multiple genes
bone marrow stroma .b 3693 to 3915 241 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base), also hits gene plarchey 223/223
(100 %)
0 diff
(100 %id)
AA991395.
matches multiple genes
breast .b 3707 to 3914 208 to 1     also hits gene plarchey 208/208
(100 %)
0 diff
(100 %id)
AK126420 uterus .b 3724 to 6744 1 to 3019   tiling clone, available from FLJ,   3019/3019
(100 %)
3 diff
(100.0 %id)
DB264913 uterus .b 3725 to 4310 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB351786 uterus .b 6221 to 6742 522 to 3       520/522
(99 %)
0 diff
(100 %id)
AW043918 pooled .b 6243 to 6745 503 to 1   tiling clone,   503/503
(100 %)
0 diff
(100 %id)
BC024296 Uterus, endometrium adenocarcinoma .c 1 to 2148 1 to 2148 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2148/2148
(100 %)
1 diff
(100.0 %id)
BC041624 Uterus, endometrium adenocarcinoma .c 1 to 2148 1 to 2148   available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2148/2148
(100 %)
1 diff
(100.0 %id)
BP381601 adipose tissue .c 773 to 1393 1 to 618   tiling clone,   618/618
(100 %)
14 diff
(97.8 %id)
CN274226 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 891 to 1633 5 to 747       743/747
(99 %)
10 diff
(98.7 %id)
CD518091 White Matter .c 1017 to 1824 27 to 837 exact     811/903
(89 %)
16 diff
(98.3 %id)
BC092415 White Matter pool- 5 brain tissues- femoralartery, olfactory tract, optic tract, cerebellar whitematter, cerebral white matter. .c 1018 to 2179 1 to 1163 exact AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1163/1163
(100 %)
1 diff
(100.0 %id)
CD559155 White Matter .c 1019 to 1455 1 to 440       440/1215
(36 %)
12 diff
(99.1 %id)
AV752918 Pituitary .c 1065 to 1716 1 to 647       647/798
(81 %)
14 diff
(98.3 %id)
N45177 liver and spleen .c 1071 to 1435 1 to 366       366/373
(98 %)
12 diff
(96.8 %id)
BP423316 small intestine .c 1084 to 1605 1 to 524     Submitted on the opposite strand 524/524
(100 %)
2 diff
(99.7 %id)
N39329 liver and spleen .c 1566 to 2179 612 to 1       612/613
(99 %)
15 diff
(97.6 %id)
NM_001001522.1   .d 1 to 1556 1 to 1556 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1556/1556
(100 %)
0 diff
(100 %id)
CD049836 embryonic stem cells, WA01, passage 38 .d 50 to 884 18 to 856   tiling clone,   839/887
(94 %)
21 diff
(97.7 %id)
AU105857   .d 50 to 99 1 to 50       50/50
(100 %)
0 diff
(100 %id)
CN412266 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 62 to 528 1 to 467       467/467
(100 %)
5 diff
(99.0 %id)
BC004927 Uterus, endometrium adenocarcinoma .d 71 to 1525 1 to 1455 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1455/1455
(100 %)
0 diff
(100 %id)
TI_57181466   .d 85 to 903 68 to 888       821/891
(92 %)
13 diff
(98.6 %id)
BE392588 endometrium, adenocarcinoma cell line, uterus .d 89 to 634 1 to 551       551/551
(100 %)
4 diff
(99.3 %id)
BI768805 pooled lung and spleen .d 94 to 903 1 to 811       811/814
(99 %)
7 diff
(99.2 %id)
BQ645072 hepatocellular carcinoma, cell line, Liver .d 416 to 1252 15 to 859 L177P Q178S M179N S181Q N182Q ...     845/958
(88 %)
32 diff
(96.7 %id)
BQ650520 hepatocellular carcinoma, cell line, Liver .d 421 to 1306 21 to 909 exact     889/910
(97 %)
18 diff
(98.1 %id)
BQ064466 lymph, lymphoma, cell line .d 423 to 1358 1 to 953 exact     953/993
(95 %)
29 diff
(97.1 %id)
BQ647293 hepatocellular carcinoma, cell line, Liver .d 424 to 1248 1 to 833 A185G G189R M190H T191D G192R ...     833/914
(91 %)
22 diff
(97.6 %id)
BQ646906 hepatocellular carcinoma, cell line, Liver .d 425 to 1384 1 to 962 A188X     962/974
(98 %)
10 diff
(99.0 %id)
BQ643590 hepatocellular carcinoma, cell line, Liver .d 425 to 1344 1 to 929 exact     929/932
(99 %)
30 diff
(96.8 %id)
AW472747 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 497 to 847 25 to 374     Submitted on the opposite strand 350/376
(93 %)
16 diff
(95.8 %id)
BI830685 brain, medulla .d 499 to 1203 1 to 701 P6L S7P Y8M G9A M10*     701/709
(98 %)
14 diff
(98.1 %id)
AA092187   .d 502 to 849 1 to 336       336/336
(100 %)
22 diff
(93.5 %id)
CN274129 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 502 to 1123 1 to 621       621/621
(100 %)
7 diff
(98.9 %id)
CN274182 embryonic stem cells, cell lines H1, H7, andH9 .d 503 to 784 1 to 282       282/282
(100 %)
10 diff
(96.5 %id)
CN274206 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 504 to 1245 1 to 741 N3T K4R G5V P6L S7P ...     741/741
(100 %)
6 diff
(99.2 %id)
BQ721799 sympathetic trunk .d 504 to 1395 1 to 902 E102*     902/905
(99 %)
25 diff
(97.3 %id)
AA345859 gall bladder .d 507 to 793 1 to 287       287/287
(100 %)
1 diff
(99.7 %id)
CN274075 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 507 to 887 2 to 382       381/382
(99 %)
0 diff
(100 %id)
ES315454 occipital scalp hair, skin .d 507 to 663 9 to 163       155/167
(92 %)
2 diff
(98.9 %id)
AA084877   .d 507 to 877 38 to 410       374/410
(91 %)
26 diff
(93.7 %id)
BQ721310 sympathetic trunk .d 507 to 1103 9 to 610       602/1059
(56 %)
18 diff
(98.4 %id)
BQ652814 hepatocellular carcinoma, cell line, Liver .d 507 to 1261 2 to 768 exact     767/922
(83 %)
17 diff
(98.2 %id)
TI_57172857   .d 507 to 1203 73 to 765 P6L S7P Y8M G9A M10*     693/773
(89 %)
12 diff
(98.5 %id)
CN274108 embryonic stem cells, cell lines H1, H7, andH9 .d 512 to 888 1 to 377       377/377
(100 %)
2 diff
(99.5 %id)
ES315165 occipital scalp hair, skin .d 512 to 650 1 to 139       139/139
(100 %)
0 diff
(100 %id)
AA491548 Ewing's sarcoma .d 512 to 875 1 to 363       363/363
(100 %)
36 diff
(90.1 %id)
AA847489 colon, colon tumor .d 512 to 975 1 to 464       464/464
(100 %)
2 diff
(99.6 %id)
TI_1948145439   .d 518 to 883 127 to 493       367/1456
(25 %)
14 diff
(99.1 %id)
BT019648   .d 519 to 1124 1 to 606 exact     606/606
(100 %)
0 diff
(100 %id)
BT019649   .d 519 to 1124 1 to 606 exact     606/606
(100 %)
0 diff
(100 %id)
CR536484   .d 519 to 1124 1 to 606 F52S     606/606
(100 %)
2 diff
(99.7 %id)
CR541681   .d 519 to 1121 1 to 603       603/603
(100 %)
0 diff
(100 %id)
CV026358 mixed .d 519 to 1123 1 to 605       605/651
(92 %)
1 diff
(99.9 %id)
M83106 aorta .d 519 to 1121 1 to 603       603/603
(100 %)
3 diff
(99.6 %id)
CN274051 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 527 to 877 1 to 351       351/351
(100 %)
0 diff
(100 %id)
CN274154 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 527 to 645 1 to 119       119/119
(100 %)
0 diff
(100 %id)
CN274162 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 528 to 876 1 to 349       349/349
(100 %)
2 diff
(99.5 %id)
CN274238 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 528 to 786 1 to 260       260/260
(100 %)
4 diff
(98.5 %id)
CN274105 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 529 to 1123 1 to 595       595/597
(99 %)
1 diff
(99.9 %id)
CN274201 embryonic stem cells, cell lines H1, H7, andH9 .d 529 to 787 1 to 259       259/259
(100 %)
1 diff
(99.7 %id)
CN274223 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 529 to 1242 1 to 715       715/715
(100 %)
1 diff
(99.9 %id)
CN274111 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 530 to 1219 1 to 690       690/690
(100 %)
0 diff
(100 %id)
CN274053 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 531 to 1151 1 to 621       621/621
(100 %)
2 diff
(99.7 %id)
CN274085 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 531 to 974 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
CN274115 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 531 to 1185 1 to 655       655/655
(100 %)
3 diff
(99.6 %id)
CF131075 Chondrosarcoma Lung Metastasis cell lines, lung .d 534 to 1254 1 to 721       721/721
(100 %)
0 diff
(100 %id)
TI_154194516   .d 534 to 1425 51 to 931       881/1018
(86 %)
18 diff
(98.3 %id)
CD616532   .d 536 to 1235 712 to 14       699/712
(98 %)
13 diff
(98.2 %id)
C18673 placenta .d 539 to 871 32 to 356       325/356
(91 %)
12 diff
(96.7 %id)
CD616526   .d 544 to 1235 698 to 12       687/699
(98 %)
9 diff
(98.8 %id)
BQ723752 sympathetic trunk .d 548 to 1411 1 to 875       875/878
(99 %)
17 diff
(98.1 %id)
CN274133 embryonic stem cells, cell lines H1, H7, andH9 .d 551 to 1159 1 to 609       609/609
(100 %)
5 diff
(99.2 %id)
CN274145 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 553 to 1144 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BQ922844 sciatic nerve .d 553 to 1358 1 to 811       811/933
(86 %)
8 diff
(99.2 %id)
BM768960 stomach .d 553 to 1071 1 to 519       519/519
(100 %)
0 diff
(100 %id)
CX788576 human embryonic stem cells .d 559 to 1377 1 to 818       818/818
(100 %)
1 diff
(99.9 %id)
CN274072 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 569 to 914 1 to 346       346/346
(100 %)
4 diff
(98.9 %id)
BM707191 eye, eye anterior segment .d 569 to 1212 1 to 644       644/644
(100 %)
4 diff
(99.4 %id)
BG675008 skin .d 577 to 1471 1 to 899       899/900
(99 %)
44 diff
(95.2 %id)
CN274207 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 583 to 801 1 to 219       219/219
(100 %)
1 diff
(99.6 %id)
CN274070 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 586 to 1057 1 to 472       472/472
(100 %)
3 diff
(99.4 %id)
CN274016 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 587 to 1051 1 to 464       464/464
(100 %)
4 diff
(99.2 %id)
CF127847 Chondrosarcoma Lung Metastasis cell lines, lung .d 587 to 1303 1 to 717       717/717
(100 %)
1 diff
(99.9 %id)
TI_154193533   .d 587 to 1471 51 to 930       880/954
(92 %)
10 diff
(99.0 %id)
AW603684 colon_normal .d 588 to 829 9 to 260       252/260
(96 %)
15 diff
(94.3 %id)
CN274091 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 591 to 782 1 to 192       192/192
(100 %)
1 diff
(99.5 %id)
CF128185 Chondrosarcoma Lung Metastasis cell lines, lung .d 592 to 1212 1 to 621       621/621
(100 %)
0 diff
(100 %id)
CF131032 Chondrosarcoma Lung Metastasis cell lines, lung .d 592 to 1188 1 to 597       597/597
(100 %)
3 diff
(99.5 %id)
BP421538 small intestine .d 594 to 1119 1 to 526     Submitted on the opposite strand 526/526
(100 %)
0 diff
(100 %id)
CN274218 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 599 to 741 1 to 143       143/143
(100 %)
0 diff
(100 %id)
CN274036 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 603 to 1314 1 to 712       712/712
(100 %)
1 diff
(99.9 %id)
CD616536   .d 606 to 1235 637 to 14       624/637
(97 %)
11 diff
(98.3 %id)
BI000811 head_normal .d 610 to 781 1 to 172       172/172
(100 %)
5 diff
(97.1 %id)
AW854402 colon .d 616 to 1218 11 to 612       602/616
(97 %)
9 diff
(98.6 %id)
H25384 breast .d 624 to 1039 1 to 419       419/424
(98 %)
11 diff
(97.5 %id)
BE927241 colon .d 626 to 1208 583 to 1       583/583
(100 %)
7 diff
(98.8 %id)
CN274203 embryonic stem cells, cell lines H1, H7, andH9 .d 627 to 739 1 to 113       113/113
(100 %)
1 diff
(99.2 %id)
AI752519 Bone, Hip .d 627 to 1046 1 to 420       420/420
(100 %)
7 diff
(98.4 %id)
CN274071 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 630 to 1123 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
TI_154108241   .d 631 to 1525 956 to 78   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 879/940
(93 %)
24 diff
(97.5 %id)
CN274185 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 632 to 895 1 to 264       264/264
(100 %)
2 diff
(99.3 %id)
BE835093 prostate_normal .d 633 to 851 20 to 238       219/238
(92 %)
8 diff
(96.7 %id)
CN274208 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 633 to 788 1 to 156       156/156
(100 %)
1 diff
(99.4 %id)
BE927252 colon .d 634 to 1218 1 to 586       586/594
(98 %)
10 diff
(98.4 %id)
AW068404 Bone, Hip .d 635 to 1087 1 to 453       453/453
(100 %)
4 diff
(99.2 %id)
BG939134 Bone, Hip .d 635 to 1118 1 to 484       484/484
(100 %)
4 diff
(99.2 %id)
AA094262   .d 637 to 776 1 to 139       139/160
(86 %)
5 diff
(96.9 %id)
DR157074 human embryonic stem cells differentiated toan early endodermal cell type .d 637 to 1384 1 to 748       748/748
(100 %)
0 diff
(100 %id)
BP264972 muscle .d 638 to 1496 1 to 875       875/1014
(86 %)
45 diff
(95.6 %id)
CD616519   .d 639 to 1212 586 to 11       576/586
(98 %)
4 diff
(99.4 %id)
CD616521   .d 639 to 1214 582 to 8       575/582
(98 %)
1 diff
(99.9 %id)
CD616523   .d 639 to 1211 571 to 1       571/571
(100 %)
4 diff
(99.3 %id)
CD616531   .d 639 to 1235 609 to 14       596/609
(97 %)
1 diff
(99.9 %id)
CD616535   .d 639 to 1235 608 to 14       595/608
(97 %)
1 diff
(99.9 %id)
CD616563   .d 639 to 1197 560 to 3       558/560
(99 %)
2 diff
(99.7 %id)
CN274043 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 642 to 806 1 to 169       169/169
(100 %)
3 diff
(98.3 %id)
TI_154193536   .d 642 to 1471 50 to 874       825/977
(84 %)
7 diff
(99.3 %id)
CF127850 Chondrosarcoma Lung Metastasis cell lines, lung .d 643 to 1376 1 to 733       733/733
(100 %)
2 diff
(99.8 %id)
CD616559   .d 645 to 1278 649 to 15       635/652
(97 %)
2 diff
(99.7 %id)
CD106885 brain, Pituitary .d 651 to 1438 1 to 794       794/857
(92 %)
9 diff
(99.0 %id)
AA360206 lymph node .d 657 to 964 1 to 308       308/308
(100 %)
1 diff
(99.7 %id)
BG680357 skin, squamous cell carcinoma .d 660 to 1381 1 to 718       718/718
(100 %)
6 diff
(99.2 %id)
ES314456 occipital scalp hair, skin .d 661 to 833 1 to 171       171/171
(100 %)
2 diff
(98.9 %id)
CN274200 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 665 to 788 1 to 124       124/124
(100 %)
0 diff
(100 %id)
H42619 breast .d 667 to 832 1 to 166       166/166
(100 %)
0 diff
(100 %id)
BE906170 epithelioid carcinoma, Pancreas .d 670 to 1362 1 to 703       703/839
(83 %)
26 diff
(97.0 %id)
AW361945 colon .d 673 to 1295 647 to 24       624/648
(96 %)
1 diff
(99.9 %id)
R45883   .d 682 to 798 1 to 117       117/117
(100 %)
0 diff
(100 %id)
AA376268 lung .d 686 to 976 1 to 294       294/294
(100 %)
5 diff
(98.3 %id)
ES310076 scalp interfollicular dermis, skin .d 694 to 1049 1 to 360       360/360
(100 %)
5 diff
(98.7 %id)
BF848037 lung_normal .d 698 to 883 19 to 203       185/211
(87 %)
4 diff
(98.2 %id)
AA326705 brain, cerebellum .d 720 to 941 1 to 223       223/223
(100 %)
1 diff
(99.6 %id)
FN162851 breast carcinoma .d 720 to 817 98 to 1     Submitted on the opposite strand 98/103
(95 %)
0 diff
(100 %id)
ES314608 occipital scalp hair, skin .d 734 to 854 1 to 121       121/121
(100 %)
0 diff
(100 %id)
ES314956 occipital scalp hair, skin .d 745 to 922 1 to 178       178/178
(100 %)
0 diff
(100 %id)
ES314640 occipital scalp hair, skin .d 758 to 905 1 to 148       148/148
(100 %)
1 diff
(99.4 %id)
ES314173 occipital scalp hair, skin .d 817 to 963 1 to 147       147/147
(100 %)
0 diff
(100 %id)
AI623986 adenocarcinoma, Pancreas .d 847 to 1552 707 to 2       664/707
(93 %)
12 diff
(98.4 %id)
BQ027112 Chondrosarcoma, Left Pubic Bone .d 873 to 1556 702 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 684/684
(100 %)
0 diff
(100 %id)
BU627814 Bone, Enchondroma cell line .d 873 to 1543 671 to 1       671/671
(100 %)
0 diff
(100 %id)
AA320531 adipose tissue, white .d 980 to 1169 2 to 191       190/191
(99 %)
0 diff
(100 %id)
BQ004206 Chondrosarcoma, Left Pelvis .d 980 to 1543 564 to 1       564/565
(99 %)
0 diff
(100 %id)
AI459431 colon .d 986 to 1528 543 to 1       543/543
(100 %)
0 diff
(100 %id)
CN274212 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 989 to 1525 1 to 537   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 537/537
(100 %)
0 diff
(100 %id)
ES314677 occipital scalp hair, skin .d 993 to 1160 1 to 167       167/167
(100 %)
1 diff
(99.5 %id)
AA374465 lung .d 1006 to 1232 1 to 227       227/227
(100 %)
2 diff
(99.2 %id)
AA385898 thyroid gland .d 1009 to 1228 1 to 220       220/220
(100 %)
0 diff
(100 %id)
BP385640 pancreatic islet .d 1009 to 1529 1 to 521     Submitted on the opposite strand 521/521
(100 %)
0 diff
(100 %id)
BP394200 pancreatic islet .d 1024 to 1525 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
BP390267 pancreatic islet .d 1026 to 1525 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BP392220 pancreatic islet .d 1026 to 1525 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AI754513 bone marrow stroma .d 1027 to 1543 517 to 1       517/517
(100 %)
0 diff
(100 %id)
BP391310 pancreatic islet .d 1028 to 1525 1 to 498     Submitted on the opposite strand 498/498
(100 %)
0 diff
(100 %id)
BP390941 pancreatic islet .d 1029 to 1527 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
BP385815 pancreatic islet .d 1030 to 1529 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BP388973 pancreatic islet .d 1030 to 1531 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
BP386414 pancreatic islet .d 1032 to 1532 1 to 501     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
AA434325 ovarian tumor, ovary .d 1033 to 1402 1 to 369   fully sequenced,   369/369
(100 %)
3 diff
(99.2 %id)
BP384517 pancreatic islet .d 1034 to 1531 1 to 498     Submitted on the opposite strand 498/498
(100 %)
0 diff
(100 %id)
DB573404 hypothalamus .d 1059 to 1525 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
AW797048 uterus .d 1072 to 1251 1 to 180       180/180
(100 %)
0 diff
(100 %id)
H25385 breast .d 1130 to 1525 395 to 1       395/395
(100 %)
4 diff
(99.0 %id)
AI750726 Bone, Hip .d 1148 to 1545 403 to 6       398/403
(98 %)
0 diff
(100 %id)
AI752580 Bone, Hip .d 1175 to 1519 353 to 9       345/353
(97 %)
0 diff
(100 %id)
AI751256 Bone, Hip .d 1178 to 1502 332 to 8       325/332
(97 %)
0 diff
(100 %id)
CN274079 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1193 to 1481 289 to 1     Submitted on the opposite strand 289/289
(100 %)
3 diff
(99.0 %id)
ES309918 scalp interfollicular dermis, skin .d 1230 to 1525 1 to 296   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 296/296
(100 %)
0 diff
(100 %id)
AA434240 ovarian tumor, ovary .d 1372 to 1526 154 to 1   fully sequenced,   154/154
(100 %)
0 diff
(100 %id)
AL047532 uterus .d 1383 to 1510 149 to 22   AAA   128/128
(100 %)
0 diff
(100 %id)
AW384178 head_neck .d 1388 to 1495 108 to 1       108/108
(100 %)
0 diff
(100 %id)
BE693488 breast .d 1388 to 1495 108 to 1       108/108
(100 %)
0 diff
(100 %id)
BQ303176 breast .d 1388 to 1495 108 to 1       108/108
(100 %)
0 diff
(100 %id)
ES315139 occipital scalp hair, skin .d 1408 to 1543 136 to 1     Submitted on the opposite strand 136/136
(100 %)
0 diff
(100 %id)
AA983377 Kidney, kidney tumor .e 1 to 501 1 to 498 R5A L6W G7A F8S Q9R ... tiling clone, Submitted on the opposite strand 498/498
(100 %)
13 diff
(97.4 %id)
TI_149312614   .e 24 to 848 916 to 97       820/1068
(76 %)
32 diff
(97.1 %id)
TI_154062007   .e 24 to 883 947 to 97   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 851/1000
(85 %)
23 diff
(97.7 %id)
TI_153958366   .e 28 to 782 80 to 833       754/1000
(75 %)
17 diff
(98.3 %id)
CN274137 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 32 to 474 1 to 443       443/443
(100 %)
3 diff
(99.4 %id)
TI_149312533   .e 32 to 884 909 to 64       846/1063
(79 %)
12 diff
(98.9 %id)
TI_154048104   .e 32 to 856 901 to 87   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 815/988
(82 %)
15 diff
(98.5 %id)
TI_154053321   .e 32 to 856 908 to 95   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 814/951
(85 %)
12 diff
(98.8 %id)
TI_154107866   .e 32 to 856 869 to 53   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 817/950
(86 %)
16 diff
(98.4 %id)
TI_227713236   .e 32 to 874 876 to 43       834/1055
(79 %)
10 diff
(99.1 %id)
AA593160 Prostate, prostatic intraepithelial neoplasia - highgrade .e 33 to 442 1 to 409       409/409
(100 %)
7 diff
(98.3 %id)
TI_149312417   .e 34 to 887 927 to 87   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 841/946
(88 %)
26 diff
(97.3 %id)
TI_154108126   .e 34 to 856 899 to 88   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 812/913
(88 %)
16 diff
(98.3 %id)
CN274228 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 36 to 631 1 to 599       599/599
(100 %)
7 diff
(98.9 %id)
AW377420 colon .e 46 to 623 577 to 1       577/577
(100 %)
3 diff
(99.5 %id)
BG983577 colon_normal .e 46 to 338 1 to 293       293/293
(100 %)
0 diff
(100 %id)
BI007524 kidney_tumor .e 46 to 445 1 to 401       401/401
(100 %)
1 diff
(99.8 %id)
BI045655 prostate_normal .e 46 to 535 492 to 4       489/492
(99 %)
3 diff
(99.4 %id)
CA390245 eye, RPE/choroid .e 47 to 653 1 to 607       607/607
(100 %)
0 diff
(100 %id)
CN274158 embryonic stem cells, cell lines H1, H7, andH9 .e 51 to 419 8 to 376       369/376
(98 %)
6 diff
(98.5 %id)
BG009373 placenta_normal .e 53 to 445 3 to 395       393/395
(99 %)
7 diff
(98.3 %id)
TI_149293097   .e 56 to 876 902 to 87   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 816/819
(99 %)
18 diff
(97.9 %id)
BF883708 lung_tumor .e 61 to 378 320 to 3     Submitted on the opposite strand 318/324
(98 %)
0 diff
(100 %id)
AA373680 lung .e 68 to 405 1 to 340       340/340
(100 %)
2 diff
(99.5 %id)
AA375640 lung .e 70 to 376 1 to 308       308/308
(100 %)
2 diff
(99.4 %id)
BF823117 kidney_tumor .e 78 to 445 1 to 368       368/368
(100 %)
3 diff
(99.2 %id)
AW361439 colon .e 86 to 538 1 to 453       453/453
(100 %)
9 diff
(98.1 %id)
EL947727 eyeball .e 86 to 527 1 to 442       442/442
(100 %)
3 diff
(99.4 %id)
AA363440 ovary .e 89 to 377 1 to 289       289/289
(100 %)
0 diff
(100 %id)
BM709139 eye, RPE and Choroid .e 90 to 397 1 to 308       308/308
(100 %)
0 diff
(100 %id)
BM716170 eye, RPE and Choroid .e 90 to 783 1 to 694       694/694
(100 %)
0 diff
(100 %id)
TI_151745122   .e 90 to 877 859 to 72       788/1098
(71 %)
10 diff
(99.1 %id)
BM928681 hepatocellular carcinoma, cell line, Liver .e 104 to 860 1 to 756       756/756
(100 %)
4 diff
(99.5 %id)
CA421189 Bone, Enchondroma cell line .e 111 to 874 759 to 1       759/759
(100 %)
5 diff
(99.4 %id)
CA412363 Chondrosarcoma Grade II, Left Pelvis .e 115 to 874 759 to 1       759/759
(100 %)
2 diff
(99.8 %id)
BQ004811 Chondrosarcoma, Left Pelvis .e 116 to 874 758 to 1       758/758
(100 %)
1 diff
(99.9 %id)
CA414788 Chondrosarcoma Grade II, Left Pelvis .e 118 to 874 754 to 1       754/754
(100 %)
5 diff
(99.4 %id)
BI765701 pooled colon, kidney, stomach .e 122 to 725 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
TI_57149309   .e 122 to 725 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
BQ010086 Chondrosarcoma, Left Pubic Bone .e 123 to 874 749 to 1       749/753
(99 %)
3 diff
(99.7 %id)
BM689216 eye, eye anterior segment .e 128 to 505 8 to 385   fully sequenced,   378/385
(98 %)
7 diff
(98.2 %id)
BQ652631 hepatocellular carcinoma, cell line, Liver .e 129 to 856 1 to 728   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 728/728
(100 %)
0 diff
(100 %id)
BQ109396 pooled colon, kidney, stomach .e 130 to 832 1 to 704       704/704
(100 %)
2 diff
(99.8 %id)
TI_149288618   .e 141 to 884 795 to 52       744/795
(93 %)
0 diff
(100 %id)
AW938082 denis_drash .e 143 to 626 485 to 3     Submitted on the opposite strand 483/485
(99 %)
0 diff
(100 %id)
BM978102 lung .e 144 to 874 731 to 1       731/731
(100 %)
1 diff
(99.9 %id)
TI_149291103   .e 147 to 856 770 to 62   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 709/709
(100 %)
5 diff
(99.3 %id)
CN484777 eye .e 153 to 778 1 to 626       626/626
(100 %)
0 diff
(100 %id)
BQ010011 Chondrosarcoma, Left Pubic Bone .e 153 to 874 722 to 1       722/722
(100 %)
0 diff
(100 %id)
BQ008129 Chondrosarcoma, Left Pelvis .e 153 to 874 722 to 1       722/722
(100 %)
0 diff
(100 %id)
CA414910 Chondrosarcoma Grade II, Left Pelvis .e 153 to 874 721 to 1       721/721
(100 %)
1 diff
(99.9 %id)
CN274020 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 155 to 759 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BQ446861 Knee, Osteoarthritic Cartilage .e 160 to 874 715 to 1       715/715
(100 %)
3 diff
(99.6 %id)
TI_57146230   .e 164 to 864 77 to 777       701/936
(74 %)
14 diff
(98.6 %id)
AW605607 denis_drash .e 166 to 632 467 to 2       466/467
(99 %)
0 diff
(100 %id)
CN274187 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 166 to 718 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BM988481 lung, Metastatic Chondrosarcoma .e 167 to 874 708 to 1       708/708
(100 %)
0 diff
(100 %id)
TI_149277716   .e 169 to 884 770 to 56       715/770
(92 %)
3 diff
(99.7 %id)
AA367378 Pancreas .e 170 to 463 1 to 294       294/296
(99 %)
1 diff
(99.7 %id)
CF127230 Chondrosarcoma Lung Metastasis cell lines, lung .e 171 to 578 1 to 408       408/408
(100 %)
2 diff
(99.6 %id)
BM668371 eye, Retina Foveal and Macular .e 172 to 874 703 to 1       703/703
(100 %)
0 diff
(100 %id)
CN274117 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 175 to 426 1 to 252       252/252
(100 %)
3 diff
(98.9 %id)
TI_149277378   .e 175 to 884 768 to 60       709/769
(92 %)
0 diff
(100 %id)
CA447281 Chondrosarcoma, Left Pelvis .e 176 to 874 699 to 1       699/699
(100 %)
0 diff
(100 %id)
BU627973 Bone, Enchondroma cell line .e 176 to 874 699 to 1       699/699
(100 %)
0 diff
(100 %id)
CN274056 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 177 to 856 1 to 680   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 680/680
(100 %)
0 diff
(100 %id)
BM970447 lung .e 177 to 874 698 to 1       698/698
(100 %)
0 diff
(100 %id)
CA415087 Chondrosarcoma Grade II, Left Pelvis .e 177 to 874 698 to 1       698/698
(100 %)
1 diff
(99.9 %id)
CA421692 Bone, Enchondroma cell line .e 177 to 874 698 to 1       698/698
(100 %)
0 diff
(100 %id)
CB529229 Aveolar Macrophage, lung .e 177 to 874 698 to 1       698/698
(100 %)
0 diff
(100 %id)
TI_154017033   .e 181 to 887 800 to 90   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 711/712
(99 %)
17 diff
(97.7 %id)
BU677897 lung .e 190 to 874 684 to 1       684/684
(100 %)
3 diff
(99.6 %id)
AA373443 lung .e 192 to 486 1 to 297       297/298
(99 %)
7 diff
(97.7 %id)
BM662594 eye, eye anterior segment .e 475 to 874 400 to 1   fully sequenced,   400/400
(100 %)
0 diff
(100 %id)
DB234112 trachea .f 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
CV401144 nervous_normal .f 398 to 590 193 to 1     Submitted on the opposite strand 193/193
(100 %)
1 diff
(99.5 %id)
AB209555 brain .f 515 to 3812 1 to 3298 exact tiling clone,   3298/3298
(100 %)
2 diff
(100.0 %id)
CV401143 nervous_normal .f 606 to 731 129 to 3     Submitted on the opposite strand 127/129
(98 %)
0 diff
(100 %id)
AL041261 testis .f 608 to 1171 1 to 564       564/564
(100 %)
3 diff
(99.5 %id)
BQ722677 sympathetic trunk .f 622 to 1204 1 to 587       587/1034
(56 %)
14 diff
(98.7 %id)
BE391218 endometrium, adenocarcinoma cell line, uterus .f 1241 to 1796 1 to 557   available from MGC,   557/557
(100 %)
3 diff
(99.5 %id)
BE389077 endometrium, adenocarcinoma cell line, uterus .f 1241 to 1732 1 to 492   tiling clone, available from MGC,   492/495
(99 %)
2 diff
(99.6 %id)
BF870630 lung_tumor .f 1436 to 1775 346 to 5     Submitted on the opposite strand 342/357
(95 %)
0 diff
(100 %id)
AW889204 nervous_tumor .f 1622 to 1737 117 to 1       117/117
(100 %)
1 diff
(99.2 %id)
BI000216 head_normal .f 1694 to 1956 11 to 270       260/272
(95 %)
6 diff
(97.8 %id)
BX471587   .f 1730 to 2346 1 to 617       617/617
(100 %)
3 diff
(99.6 %id)
AI824723 adenocarcinoma, Pancreas .f 1971 to 2179 22 to 230     Submitted on the opposite strand 209/230
(90 %)
12 diff
(94.8 %id)
BF855115 prostate_normal .f 2043 to 2477 1 to 435       435/450
(96 %)
7 diff
(98.5 %id)
BF855122 prostate_normal .f 2043 to 2477 1 to 436       436/442
(98 %)
7 diff
(98.5 %id)
BF855126 prostate_normal .f 2046 to 2477 457 to 25     Submitted on the opposite strand 433/463
(93 %)
0 diff
(100 %id)
BF855128 prostate_normal .f 2046 to 2477 25 to 457       433/463
(93 %)
6 diff
(98.8 %id)
BQ371625 prostate_normal .f 2046 to 2477 31 to 464       434/470
(92 %)
14 diff
(97.1 %id)
F05615 brain, total brain .f 2173 to 2432 1 to 260       260/260
(100 %)
0 diff
(100 %id)
BE925206 amnion_normal .f 2247 to 2469 244 to 22       223/244
(91 %)
0 diff
(100 %id)
C18868 placenta .f 2489 to 2972 7 to 488       482/488
(98 %)
17 diff
(96.6 %id)
BF378459 uterus .g 1 to 408 413 to 1 A15G V16S T17D K18Q N19E ... tiling clone,   413/413
(100 %)
16 diff
(96.2 %id)
TI_154031009   .g 42 to 700 738 to 79 V4S Q5A R6E T7D L8P ... tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 660/800
(82 %)
7 diff
(99.2 %id)
AL048306 uterus .g 51 to 731 701 to 28 V4L M9D A10G L11F S13Q ... tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 674/724
(93 %)
24 diff
(96.7 %id)
BM663917 eye, RPE and Choroid .g 65 to 718 651 to 1       651/651
(100 %)
5 diff
(99.3 %id)
CA442717 lung, Lung Focal Fibrosis .g 67 to 718 652 to 1   tiling clone,   652/652
(100 %)
0 diff
(100 %id)
AA318204 retina .g 70 to 404 1 to 335       335/338
(99 %)
6 diff
(98.3 %id)
AW377483 colon .g 72 to 500 429 to 1       429/429
(100 %)
4 diff
(99.1 %id)
AW377590 colon .g 72 to 506 437 to 2       436/437
(99 %)
0 diff
(100 %id)
AW378482 head_neck .g 74 to 450 382 to 8       375/382
(98 %)
0 diff
(100 %id)
CA412584 Chondrosarcoma Grade II, Left Pelvis .g 74 to 718 645 to 1       645/645
(100 %)
0 diff
(100 %id)
CA420508 Bone, Enchondroma cell line .g 74 to 718 645 to 1       645/645
(100 %)
0 diff
(100 %id)
BU627208 Bone, Enchondroma cell line .g 74 to 718 645 to 1       645/645
(100 %)
0 diff
(100 %id)
BQ005936 Chondrosarcoma, Left Pubic Bone .g 75 to 718 644 to 1       644/644
(100 %)
0 diff
(100 %id)
BU682453 lung .g 75 to 718 644 to 1       644/644
(100 %)
2 diff
(99.7 %id)
AW849796 colon .g 77 to 490 415 to 2       414/415
(99 %)
2 diff
(99.6 %id)
AW849879 colon .g 77 to 490 415 to 2       414/415
(99 %)
1 diff
(99.8 %id)
BE164400 head_neck .g 80 to 457 1 to 380       380/380
(100 %)
5 diff
(98.7 %id)
ES311853 frontal balding hair, skin .g 87 to 278 1 to 192       192/192
(100 %)
0 diff
(100 %id)
AI720810 colon .g 90 to 703 612 to 1       612/612
(100 %)
6 diff
(99.1 %id)
CA423369 cell lines, Chondrosarcoma .g 93 to 718 627 to 1       627/627
(100 %)
1 diff
(99.9 %id)
BF809030 colon_ins .g 98 to 486 1 to 388       388/388
(100 %)
2 diff
(99.5 %id)
TI_153949605   .g 101 to 719 83 to 703       621/1142
(54 %)
16 diff
(98.6 %id)
BU736779 eye, RPE and Choroid .g 116 to 718 603 to 1       603/603
(100 %)
0 diff
(100 %id)
TI_57173933   .g 122 to 732 30 to 643       614/762
(80 %)
17 diff
(97.8 %id)
AA320936 adipose tissue, white .g 132 to 443 1 to 313       313/313
(100 %)
4 diff
(98.8 %id)
CN411916 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h-u 1 to 608 6 to 614 exact tiling clone,   614/614
(100 %)
2 diff
(99.7 %id)
BG982542 colon_normal .h-u 48 to 432 1 to 385       385/385
(100 %)
1 diff
(99.8 %id)
486 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI